Enhanced sensitivity of flow cytometry for routine assessment of minimal residual disease
- PMID: 19951967
- PMCID: PMC2857207
- DOI: 10.3324/haematol.2009.018911
Enhanced sensitivity of flow cytometry for routine assessment of minimal residual disease
Comment on
-
How and why minimal residual disease studies are necessary in leukemia: a review from WP10 and WP12 of the European LeukaemiaNet.Haematologica. 2009 Aug;94(8):1135-50. doi: 10.3324/haematol.2008.004267. Epub 2009 Jul 7. Haematologica. 2009. PMID: 19586938 Free PMC article. Review.
Similar articles
-
Monitoring minimal residual disease in pediatric hematologic malignancies.Clin Adv Hematol Oncol. 2007 Nov;5(11):876-7, 915. Clin Adv Hematol Oncol. 2007. PMID: 18185484 Review. No abstract available.
-
Minimal residual disease in leukaemia patients.Lancet Oncol. 2001 Jul;2(7):409-17. doi: 10.1016/s1470-2045(00)00418-6. Lancet Oncol. 2001. PMID: 11905735 Review.
-
[Minimal residual disease. Methodologies and clinical implications].Sangre (Barc). 1999 Aug;44(4):283-90. Sangre (Barc). 1999. PMID: 10589280 Review. Spanish. No abstract available.
-
Minimal residual disease detection in hairy cell leukemia. Comparison of flow cytometric immunophenotyping with clonal analysis using consensus primer polymerase chain reaction for the heavy chain gene.Am J Clin Pathol. 2003 Feb;119(2):213-7. doi: 10.1309/G629-9513-NGLC-UB1K. Am J Clin Pathol. 2003. PMID: 12579991
-
Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.Haematologica. 2008 Apr;93(4):551-9. doi: 10.3324/haematol.11267. Haematologica. 2008. PMID: 18379010 Clinical Trial.
Cited by
-
High-Sensitivity Flow Cytometry for the Reliable Detection of Measurable Residual Disease in Hematological Malignancies in Clinical Laboratories.Diseases. 2024 Dec 22;12(12):338. doi: 10.3390/diseases12120338. Diseases. 2024. PMID: 39727668 Free PMC article.
-
Residual malignant and normal plasma cells shortly after high dose melphalan and stem cell transplantation. Highlight of a putative therapeutic window in Multiple Myeloma?Oncotarget. 2012 Nov;3(11):1335-47. doi: 10.18632/oncotarget.650. Oncotarget. 2012. PMID: 23154454 Free PMC article.
-
Differential effects of lenalidomide during plasma cell differentiation.Oncotarget. 2016 May 10;7(19):28096-111. doi: 10.18632/oncotarget.8581. Oncotarget. 2016. PMID: 27057635 Free PMC article.
-
Development of a fast and precise potency test for BCG vaccine viability using flow cytometry compared to MTT and colony-forming unit assays.Sci Rep. 2023 Jul 18;13(1):11606. doi: 10.1038/s41598-023-38657-x. Sci Rep. 2023. PMID: 37464014 Free PMC article.
References
-
- Craig FE, Foon KA. Flow cytometric immunophenotyping for hematologic neoplasms. Blood. 2008;111(8):3941–67. - PubMed
-
- Krampera M, Perbellini O, Vincenzi C, Zampieri F, Pasini A, Scupoli MT, et al. Methodological approach to minimal residual disease detection by flow cytometry in adult B-lineage acute lymphoblastic leukemia. Haematologica. 2006;91(8):1109–12. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources